Reaction and Significance of Fremanezumab’s Expanded Indication in Pediatric Migraine: Patricia Pozo-Rosich, MD, PhD

The head of the neurology department at the Vall d’Hebron University Hospital shared thoughts and perspectives on significance of fremanezumab’s recently expanded approval, calling it a long-awaited breakthrough for treating pediatric migraine. [WATCH TIME: 3 minutes]